Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dyadic International (NQ: DYAI )

1.734 +0.064 (+3.81%)
Streaming Delayed Price Updated: 11:54 AM EDT, Apr 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,114
Open 1.650
Bid (Size) 1.690 (1)
Ask (Size) 1.840 (1)
Prev. Close 1.670
Today's Range 1.650 - 1.785
52wk Range 1.190 - 2.400
Shares Outstanding 28,811,061
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Momentum Stocks Alert: DYAI, KAVL, VTAK, NKLA, ATAI Demonstrate Financial Growth and Strategic Advancements
Via AB Newswire
Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report
Via AB Newswire
Topics Regulatory Compliance
Exposures Legal Regulatory

Performance

YTD
+9.03%
+9.03%
1 Month
+9.72%
+9.72%
3 Month
+14.05%
+14.05%
6 Month
-9.24%
-9.24%
1 Year
-4.78%
-4.78%

More News

Read More
DYAI Stock Earnings: Dyadic International Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Recap: Dyadic International Q4 Earnings
Via Benzinga
Dyadic Announces Change in Board and Management Leadership Roles
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic International's Earnings: A Preview
Via Benzinga
Reddit Inc. (NYSE: RDDT) Surges, Uncovering Undervalued Opportunities: DYAI, INBS, MESO, VTAK
Via AB Newswire
Topics Initial Public Offering
Exposures Product Safety Securities Market
Dyadic International, Inc. (NASDAQ: DYAI) on “The Street Podcast” and Featured in Prestigious Science and Technology Journal – Tune In and Dive In!
Via AB Newswire
Dyadic to Attend Industry Events in April
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic International Inc. (NASDAQ: DYAI): A Value Play Gaining Investor Attention
Via AB Newswire
Earnings Scheduled For March 28, 2024
Via Benzinga
Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms
Via AB Newswire
Topics Supply Chain
Exposures Supply Chain
Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
From Dyadic International, Inc.
Via GlobeNewswire
Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP
Via AB Newswire
CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
From Dyadic International, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
From Dyadic International, Inc.
Via GlobeNewswire
Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
Via AB Newswire
Exposures Product Safety
Biotech Breakthroughs: Dyadic International (NASDAQ: DYAI) Partners with Rabian BV to Combat Rabies
Via AB Newswire
Topics Death
Exposures Death
Dyadic to Attend Industry Events in March
From Dyadic International, Inc.
Via GlobeNewswire
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
Via AB Newswire
Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform
From Dyadic International, Inc.
Via GlobeNewswire
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI
Via AB Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.